Skip to search boxSkip to navigationSkip to main content

Nonclassical Monocytes in Health and Disease

Scholary Output:
Contribution to journal
Review article
Peer-review

Abstract

Monocytes are innate blood cells that maintain vascular homeostasis and are early responders to pathogens in acute infections. There are three well-characterized classes of monocytes: classical (CD14+CD16- in humans and Ly6Chi in mice), intermediate (CD14+CD16+ in humans and Ly6C+Treml4+ in mice), and nonclassical (CD14-CD16+ in humans and Ly6Clo in mice). Classical monocytes are critical for the initial inflammatory response. Classical monocytes can differentiate into macrophages in tissue and can contribute to chronic disease. Nonclassical monocytes have been widely viewed as anti-inflammatory, as they maintain vascular homeostasis. They are a first line of defense in recognition and clearance of pathogens. However, their roles in chronic disease are less clear. They have been shown to be protective as well as positively associated with disease burden. This review focuses on the state of the monocyte biology field and the functions of monocytes, particularly nonclassical monocytes, in health and disease.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 439-456 (18 pages)

Journal (Volume, Issue Number)

Annual Review of Immunology (Volume 37)

Publication milestones

  • Published - 04/26/2019

Publication status

Published - 04/26/2019

ISSN

0732-0582

Publication IDs

  • Scopus: 85065027203
  • PubMed: 31026415

Publication metrics

Metrics

Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
438
Captures
419

Funding Details

This work was supported by the National Institutes of Health: NIH F31 HL132538 (to P.M.M.) and NIH R01 HL134236, HL118765, P01 HL055798, and P01 HL136275 (all to C.C.H.).
FundersFunding numbers
NIH
R01 HL134236, NIH F31 HL132538, HL118765, P01 HL136275
NHLBI
P01HL055798